HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-MAY-15 4ZYT TITLE HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND N-{4-[4-(2-AMINO-4- TITLE 2 OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-6-YL)BENZYL]BENZOYL}-L- TITLE 3 GLUTAMIC ACID (AGF23) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GAR TRANSFORMYLASE DOMAIN; COMPND 5 EC: 2.1.2.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GART, PGFT, PRGS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS GAR TRANSFORMYLASE, ANTIFOLATE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.M.DEIS,C.E.DANN III REVDAT 5 27-SEP-23 4ZYT 1 REMARK REVDAT 4 04-DEC-19 4ZYT 1 REMARK REVDAT 3 20-SEP-17 4ZYT 1 REMARK REVDAT 2 22-FEB-17 4ZYT 1 JRNL REVDAT 1 20-APR-16 4ZYT 0 JRNL AUTH S.M.DEIS,A.DOSHI,Z.HOU,L.H.MATHERLY,A.GANGJEE,C.E.DANN JRNL TITL STRUCTURAL AND ENZYMATIC ANALYSIS OF TUMOR-TARGETED JRNL TITL 2 ANTIFOLATES THAT INHIBIT GLYCINAMIDE RIBONUCLEOTIDE JRNL TITL 3 FORMYLTRANSFERASE. JRNL REF BIOCHEMISTRY V. 55 4574 2016 JRNL REFN ISSN 1520-4995 JRNL PMID 27439469 JRNL DOI 10.1021/ACS.BIOCHEM.6B00412 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX PHENIX.REFINE 1.9 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.79 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 67458 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.183 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.660 REMARK 3 FREE R VALUE TEST SET COUNT : 3816 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.8020 - 5.1020 0.98 2392 149 0.1545 0.1400 REMARK 3 2 5.1020 - 4.0509 1.00 2427 139 0.1329 0.1347 REMARK 3 3 4.0509 - 3.5392 1.00 2471 138 0.1429 0.1686 REMARK 3 4 3.5392 - 3.2158 1.00 2431 144 0.1741 0.2251 REMARK 3 5 3.2158 - 2.9854 1.00 2416 154 0.1828 0.1647 REMARK 3 6 2.9854 - 2.8094 1.00 2461 144 0.1773 0.1962 REMARK 3 7 2.8094 - 2.6687 1.00 2426 154 0.1805 0.2126 REMARK 3 8 2.6687 - 2.5526 1.00 2443 143 0.1699 0.1827 REMARK 3 9 2.5526 - 2.4543 1.00 2446 139 0.1610 0.1772 REMARK 3 10 2.4543 - 2.3696 1.00 2408 144 0.1639 0.1860 REMARK 3 11 2.3696 - 2.2956 1.00 2455 150 0.1584 0.1903 REMARK 3 12 2.2956 - 2.2299 1.00 2430 137 0.1526 0.1884 REMARK 3 13 2.2299 - 2.1712 1.00 2448 146 0.1535 0.1662 REMARK 3 14 2.1712 - 2.1183 1.00 2454 150 0.1508 0.1618 REMARK 3 15 2.1183 - 2.0701 1.00 2416 144 0.1537 0.1746 REMARK 3 16 2.0701 - 2.0261 1.00 2394 146 0.1697 0.1827 REMARK 3 17 2.0261 - 1.9855 1.00 2462 148 0.1707 0.1961 REMARK 3 18 1.9855 - 1.9481 1.00 2446 148 0.1776 0.1908 REMARK 3 19 1.9481 - 1.9133 1.00 2411 146 0.1917 0.1922 REMARK 3 20 1.9133 - 1.8809 1.00 2455 138 0.1927 0.2002 REMARK 3 21 1.8809 - 1.8505 1.00 2441 148 0.1887 0.2254 REMARK 3 22 1.8505 - 1.8220 1.00 2398 154 0.1898 0.2384 REMARK 3 23 1.8220 - 1.7952 1.00 2438 146 0.2015 0.2101 REMARK 3 24 1.7952 - 1.7700 0.98 2418 145 0.2076 0.2426 REMARK 3 25 1.7700 - 1.7460 0.88 2078 126 0.2290 0.2163 REMARK 3 26 1.7460 - 1.7234 0.72 1798 110 0.2140 0.2470 REMARK 3 27 1.7234 - 1.7018 0.58 1379 86 0.2292 0.1931 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1665 REMARK 3 ANGLE : 1.112 2278 REMARK 3 CHIRALITY : 0.047 267 REMARK 3 PLANARITY : 0.005 297 REMARK 3 DIHEDRAL : 12.580 606 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 808 THROUGH 855 ) REMARK 3 ORIGIN FOR THE GROUP (A): -39.0226 26.3378 23.4181 REMARK 3 T TENSOR REMARK 3 T11: 0.1969 T22: 0.0799 REMARK 3 T33: 0.1430 T12: -0.0089 REMARK 3 T13: 0.0112 T23: -0.0260 REMARK 3 L TENSOR REMARK 3 L11: 2.8424 L22: 2.0265 REMARK 3 L33: 4.0689 L12: 1.0056 REMARK 3 L13: -1.5392 L23: -0.1209 REMARK 3 S TENSOR REMARK 3 S11: 0.0468 S12: 0.1035 S13: 0.3302 REMARK 3 S21: -0.2869 S22: 0.0809 S23: -0.0084 REMARK 3 S31: -0.4758 S32: 0.0738 S33: -0.1123 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 856 THROUGH 884 ) REMARK 3 ORIGIN FOR THE GROUP (A): -24.2948 31.2438 25.4268 REMARK 3 T TENSOR REMARK 3 T11: 0.3060 T22: 0.2944 REMARK 3 T33: 0.4474 T12: -0.2089 REMARK 3 T13: 0.1041 T23: -0.1253 REMARK 3 L TENSOR REMARK 3 L11: 3.1907 L22: 1.1360 REMARK 3 L33: 0.8885 L12: -0.7451 REMARK 3 L13: 0.8532 L23: 0.5976 REMARK 3 S TENSOR REMARK 3 S11: -0.0405 S12: 0.3081 S13: 0.3924 REMARK 3 S21: -0.2814 S22: 0.1958 S23: -0.5151 REMARK 3 S31: -0.3649 S32: 0.5213 S33: 0.0577 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 885 THROUGH 954 ) REMARK 3 ORIGIN FOR THE GROUP (A): -27.6450 13.4906 22.3558 REMARK 3 T TENSOR REMARK 3 T11: 0.0979 T22: 0.2060 REMARK 3 T33: 0.1728 T12: -0.0306 REMARK 3 T13: -0.0084 T23: -0.0746 REMARK 3 L TENSOR REMARK 3 L11: 0.3900 L22: 1.1772 REMARK 3 L33: 0.8629 L12: -0.0269 REMARK 3 L13: 0.0037 L23: 0.6181 REMARK 3 S TENSOR REMARK 3 S11: 0.0026 S12: -0.1423 S13: 0.1648 REMARK 3 S21: 0.0356 S22: 0.1900 S23: -0.3387 REMARK 3 S31: -0.0438 S32: 0.4028 S33: -0.1402 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 955 THROUGH 1007 ) REMARK 3 ORIGIN FOR THE GROUP (A): -38.0268 9.8062 22.0935 REMARK 3 T TENSOR REMARK 3 T11: 0.0454 T22: 0.0712 REMARK 3 T33: 0.0906 T12: -0.0010 REMARK 3 T13: -0.0071 T23: -0.0228 REMARK 3 L TENSOR REMARK 3 L11: 1.0163 L22: 1.6838 REMARK 3 L33: 3.2937 L12: -0.1039 REMARK 3 L13: -0.6090 L23: 0.4668 REMARK 3 S TENSOR REMARK 3 S11: -0.0408 S12: -0.0808 S13: 0.0730 REMARK 3 S21: 0.1502 S22: 0.0848 S23: -0.0682 REMARK 3 S31: 0.1132 S32: 0.1906 S33: -0.0134 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZYT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000210120. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 4.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0001 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK SI(111) SAGITALLY REMARK 200 FOCUSED MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CMOS REMARK 200 DETECTOR MANUFACTURER : RDI CMOS_8M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67458 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.45700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: 4X73 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18 % PEG4000, 2 % PEG400, 0.33 M NACL, REMARK 280 PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.03333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.51667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 33.51667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 67.03333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 807 REMARK 465 LYS A 1008 REMARK 465 GLU A 1009 REMARK 465 GLU A 1010 REMARK 465 HIS A 1011 REMARK 465 HIS A 1012 REMARK 465 HIS A 1013 REMARK 465 HIS A 1014 REMARK 465 HIS A 1015 REMARK 465 HIS A 1016 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 866 CG CD CE NZ REMARK 470 LYS A 869 CG CD CE NZ REMARK 470 GLU A1000 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1310 O HOH A 1364 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 896 53.65 -107.29 REMARK 500 THR A 939 -152.57 -123.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1373 DISTANCE = 5.84 ANGSTROMS REMARK 525 HOH A1374 DISTANCE = 6.62 ANGSTROMS REMARK 525 HOH A1375 DISTANCE = 6.76 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GAR A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3Y9 A 1102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4EW2 RELATED DB: PDB REMARK 900 4EW2 IS THE SAME PROTEIN COMPLEXED WITH 10S-METHYLTHIO-DDATHF REMARK 900 RELATED ID: 4EW3 RELATED DB: PDB REMARK 900 4EW3 IS THE SAME PROTEIN COMPLEXED WITH 10R-METHYLTHIO-DDATHF REMARK 900 RELATED ID: 1RBM RELATED DB: PDB REMARK 900 1RBM IS THE SAME PROTEIN COMPLEXED WITH POLYGLUTAMINATED 10- REMARK 900 (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID REMARK 900 RELATED ID: 1RBQ RELATED DB: PDB REMARK 900 1RBQ IS THE SAME PROTEIN COMPLEXED WITH 10-(TRIFLUOROACETYL)-5,10- REMARK 900 DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID REMARK 900 RELATED ID: 1RBY RELATED DB: PDB REMARK 900 1RBY IS THE SAME PROTEIN COMPLEXED WITH 10-(TRIFLUOROACETYL)-5,10- REMARK 900 DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID AND BETA-GAR REMARK 900 RELATED ID: 1RBZ RELATED DB: PDB REMARK 900 1RBZ IS THE SAME PROTEIN COMPLEXED WITH POLYGLUTAMINATED 10- REMARK 900 (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID REMARK 900 RELATED ID: 1RC0 RELATED DB: PDB REMARK 900 1RC0 IS THE SAME PROTEIN COMPLEXED WITH POLYGLUTAMINATED 10- REMARK 900 (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID REMARK 900 RELATED ID: 1RC1 RELATED DB: PDB REMARK 900 1RC1 IS THE SAME PROTEIN COMPLEXED WITH POLYGLUTAMINATED 10- REMARK 900 (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID REMARK 900 RELATED ID: 1NJS RELATED DB: PDB REMARK 900 1NJS IS THE SAME PROTEIN COMPLEXED WITH A HYDROLYZED FORM OF 10- REMARK 900 (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID REMARK 900 RELATED ID: 1MEN RELATED DB: PDB REMARK 900 1MEN IS THE SAME PROTEIN COMPLEXED WITH BETA-GAR REMARK 900 RELATED ID: 1MEJ RELATED DB: PDB REMARK 900 1MEJ IS THE SAME PROTEIN IN APO FORM AT PH 8.5 REMARK 900 RELATED ID: 1MEO RELATED DB: PDB REMARK 900 1MEO IS THE SAME PROTEIN IN APO FORM AT PH 4.2 REMARK 900 RELATED ID: 1ZLX RELATED DB: PDB REMARK 900 1ZLX IS THE SAME PROTEIN IN APO FORM REMARK 900 RELATED ID: 1ZLY RELATED DB: PDB REMARK 900 1ZLY IS THE SAME PROTEIN COMPLEXED WITH 4-[(4-{[(2-AMINO-4-OXO-3,4- REMARK 900 DIHYDROQUINAZOLIN- 6-YL)METHYL]AMINO}BENZOYL)AMINO]BUTANOIC ACID REMARK 900 AND 5-O-PHOSPHONO-BETA-D-RIBOFURANOSYLAMINE REMARK 900 RELATED ID: 4ZYU RELATED DB: PDB REMARK 900 RELATED ID: 4ZYV RELATED DB: PDB REMARK 900 RELATED ID: 4ZYW RELATED DB: PDB REMARK 900 RELATED ID: 4ZYX RELATED DB: PDB REMARK 900 RELATED ID: 4ZYY RELATED DB: PDB REMARK 900 RELATED ID: 4ZYZ RELATED DB: PDB REMARK 900 RELATED ID: 4ZZ0 RELATED DB: PDB REMARK 900 RELATED ID: 4ZZ1 RELATED DB: PDB REMARK 900 RELATED ID: 4ZZ2 RELATED DB: PDB REMARK 900 RELATED ID: 4ZZ3 RELATED DB: PDB DBREF 4ZYT A 808 1010 UNP P22102 PUR2_HUMAN 808 1010 SEQADV 4ZYT MET A 807 UNP P22102 INITIATING METHIONINE SEQADV 4ZYT HIS A 1011 UNP P22102 EXPRESSION TAG SEQADV 4ZYT HIS A 1012 UNP P22102 EXPRESSION TAG SEQADV 4ZYT HIS A 1013 UNP P22102 EXPRESSION TAG SEQADV 4ZYT HIS A 1014 UNP P22102 EXPRESSION TAG SEQADV 4ZYT HIS A 1015 UNP P22102 EXPRESSION TAG SEQADV 4ZYT HIS A 1016 UNP P22102 EXPRESSION TAG SEQRES 1 A 210 MET ALA ARG VAL ALA VAL LEU ILE SER GLY THR GLY SER SEQRES 2 A 210 ASN LEU GLN ALA LEU ILE ASP SER THR ARG GLU PRO ASN SEQRES 3 A 210 SER SER ALA GLN ILE ASP ILE VAL ILE SER ASN LYS ALA SEQRES 4 A 210 ALA VAL ALA GLY LEU ASP LYS ALA GLU ARG ALA GLY ILE SEQRES 5 A 210 PRO THR ARG VAL ILE ASN HIS LYS LEU TYR LYS ASN ARG SEQRES 6 A 210 VAL GLU PHE ASP SER ALA ILE ASP LEU VAL LEU GLU GLU SEQRES 7 A 210 PHE SER ILE ASP ILE VAL CYS LEU ALA GLY PHE MET ARG SEQRES 8 A 210 ILE LEU SER GLY PRO PHE VAL GLN LYS TRP ASN GLY LYS SEQRES 9 A 210 MET LEU ASN ILE HIS PRO SER LEU LEU PRO SER PHE LYS SEQRES 10 A 210 GLY SER ASN ALA HIS GLU GLN ALA LEU GLU THR GLY VAL SEQRES 11 A 210 THR VAL THR GLY CYS THR VAL HIS PHE VAL ALA GLU ASP SEQRES 12 A 210 VAL ASP ALA GLY GLN ILE ILE LEU GLN GLU ALA VAL PRO SEQRES 13 A 210 VAL LYS ARG GLY ASP THR VAL ALA THR LEU SER GLU ARG SEQRES 14 A 210 VAL LYS LEU ALA GLU HIS LYS ILE PHE PRO ALA ALA LEU SEQRES 15 A 210 GLN LEU VAL ALA SER GLY THR VAL GLN LEU GLY GLU ASN SEQRES 16 A 210 GLY LYS ILE CYS TRP VAL LYS GLU GLU HIS HIS HIS HIS SEQRES 17 A 210 HIS HIS HET GAR A1101 18 HET 3Y9 A1102 33 HETNAM GAR GLYCINAMIDE RIBONUCLEOTIDE HETNAM 3Y9 N-{4-[4-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3- HETNAM 2 3Y9 D]PYRIMIDIN-6-YL)BUTYL]BENZOYL}-L-GLUTAMIC ACID FORMUL 2 GAR C7 H13 N2 O8 P 2- FORMUL 3 3Y9 C22 H25 N5 O6 FORMUL 4 HOH *175(H2 O) HELIX 1 AA1 GLY A 818 ARG A 829 1 12 HELIX 2 AA2 VAL A 847 ALA A 856 1 10 HELIX 3 AA3 ASN A 864 TYR A 868 5 5 HELIX 4 AA4 ASN A 870 PHE A 885 1 16 HELIX 5 AA5 SER A 900 TRP A 907 1 8 HELIX 6 AA6 ASN A 926 GLY A 935 1 10 HELIX 7 AA7 THR A 968 SER A 993 1 26 SHEET 1 AA1 7 THR A 860 VAL A 862 0 SHEET 2 AA1 7 GLN A 836 SER A 842 1 N SER A 842 O ARG A 861 SHEET 3 AA1 7 ARG A 809 ILE A 814 1 N VAL A 810 O GLN A 836 SHEET 4 AA1 7 ILE A 889 LEU A 892 1 O CYS A 891 N LEU A 813 SHEET 5 AA1 7 MET A 911 HIS A 915 1 O LEU A 912 N LEU A 892 SHEET 6 AA1 7 VAL A 938 PHE A 945 -1 O THR A 942 N HIS A 915 SHEET 7 AA1 7 ILE A 955 PRO A 962 -1 O VAL A 961 N THR A 939 SHEET 1 AA2 2 VAL A 996 LEU A 998 0 SHEET 2 AA2 2 ILE A1004 TRP A1006 -1 O CYS A1005 N GLN A 997 CISPEP 1 LEU A 919 PRO A 920 0 13.24 SITE 1 AC1 20 THR A 817 GLY A 818 SER A 819 ASN A 820 SITE 2 AC1 20 GLY A 894 MET A 896 HIS A 915 PRO A 916 SITE 3 AC1 20 GLY A 924 LYS A 977 GLU A 980 3Y9 A1102 SITE 4 AC1 20 HOH A1217 HOH A1224 HOH A1226 HOH A1228 SITE 5 AC1 20 HOH A1238 HOH A1252 HOH A1277 HOH A1304 SITE 1 AC2 19 LYS A 844 HIS A 865 ARG A 871 PHE A 895 SITE 2 AC2 19 MET A 896 ARG A 897 ILE A 898 LEU A 899 SITE 3 AC2 19 VAL A 904 HIS A 944 VAL A 946 ALA A 947 SITE 4 AC2 19 GLU A 948 VAL A 950 ASP A 951 GAR A1101 SITE 5 AC2 19 HOH A1217 HOH A1233 HOH A1300 CRYST1 75.174 75.174 100.550 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013302 0.007680 0.000000 0.00000 SCALE2 0.000000 0.015360 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009945 0.00000